Mezzion Pharma Co.,Ltd. (KOSDAQ: 140410)

Mezzion Pharma Co.,Ltd. Statistics

Total Valuation

Mezzion Pharma Co.,Ltd. has a market cap or net worth of KRW 925.87 billion. The enterprise value is 885.48 billion.

Market Cap	925.87B
Enterprise Value	885.48B

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Mezzion Pharma Co.,Ltd. has 29.96 million shares outstanding. The number of shares has increased by 10.53% in one year.

Current Share Class	n/a
Shares Outstanding	29.96M
Shares Change (YoY)	+10.53%
Shares Change (QoQ)	-0.28%
Owned by Insiders (%)	9.48%
Owned by Institutions (%)	5.89%
Float	21.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	45.24
PB Ratio	16.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-99.85
EV / Sales	43.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-69.26

Financial Position

The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.01.

Current Ratio	2.65
Quick Ratio	2.01
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-44.99

Financial Efficiency

Return on equity (ROE) is -14.54% and return on invested capital (ROIC) is -15.12%.

Return on Equity (ROE)	-14.54%
Return on Assets (ROA)	-11.45%
Return on Capital (ROIC)	-15.12%
Revenue Per Employee	1.19B
Profits Per Employee	-521.66M
Employee Count	17
Asset Turnover	0.24
Inventory Turnover	2.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.32%
50-Day Moving Average	31,042.00
200-Day Moving Average	35,930.50
Relative Strength Index (RSI)	46.12
Average Volume (20 Days)	112,081

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mezzion Pharma Co.,Ltd. had revenue of KRW 20.25 billion and -8.87 billion in losses. Loss per share was -299.41.

Revenue	20.25B
Gross Profit	3.22B
Operating Income	-15.22B
Pretax Income	-8.45B
Net Income	-8.87B
EBITDA	-13.94B
EBIT	-15.22B
Loss Per Share	-299.41

Balance Sheet

The company has 41.12 billion in cash and 732.03 million in debt, giving a net cash position of 40.39 billion or 1,347.99 per share.

Cash & Cash Equivalents	41.12B
Total Debt	732.03M
Net Cash	40.39B
Net Cash Per Share	1,347.99
Equity (Book Value)	55.07B
Book Value Per Share	1,846.60
Working Capital	35.42B

Cash Flow

In the last 12 months, operating cash flow was -12.07 billion and capital expenditures -714.00 million, giving a free cash flow of -12.79 billion.

Operating Cash Flow	-12.07B
Capital Expenditures	-714.00M
Free Cash Flow	-12.79B
FCF Per Share	-426.70

Margins

Gross margin is 15.93%, with operating and profit margins of -75.16% and -43.80%.

Gross Margin	15.93%
Operating Margin	-75.16%
Pretax Margin	-41.75%
Profit Margin	-43.80%
EBITDA Margin	-68.84%
EBIT Margin	-75.16%
FCF Margin	-63.15%

Dividends & Yields

Mezzion Pharma Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.53%
Shareholder Yield	-10.53%
Earnings Yield	-0.97%
FCF Yield	-1.38%

Stock Splits

The last stock split was on April 5, 2022. It was a forward split with a ratio of 3.

Last Split Date	Apr 5, 2022
Split Type	Forward
Split Ratio	3

Scores

Mezzion Pharma Co.,Ltd. has an Altman Z-Score of 29.05.

Altman Z-Score	29.05
Piotroski F-Score	n/a